Text Only | SAMHSA News Home

SAMHSA News - November/December 2004, Volume 12, Number 6

Facts about Rapid HIV Testing

photo of OraQuick® ADVANCE Rapid HIV-1/2 
                    Antibody Test device and packagingSAMHSA's new Rapid HIV Testing Initiative uses the OraQuick® ADVANCE Rapid HIV-1/2 Antibody Test.

The test kit consists of a single-use test device and a single-use test developer solution. Additional items provided include a reusable test stand and disposable specimen collection loop.

Test results are provided with greater than 99-percent accuracy in as little as 20 minutes.

Other facts about this product include:

  • The OraQuick® ADVANCE Rapid HIV-1/2 Antibody Test is the first and only rapid, point-of-care test approved by the U.S. Food and Drug Administration (FDA).

  • In June 2004, the FDA approved a waiver under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) for the OraQuick® ADVANCE test.

  • The test is available for use by more than 180,000 sites registered under CLIA in the United States, including hospitals, physicians' offices, health clinics, outreach clinics, HIV counseling centers, and community-based organizations.

  • Unlike other antibody tests for HIV, OraQuick® ADVANCE can be stored at room temperature and requires no specialized equipment.

Back to Top

How the Oral Test Works

The "lateral-flow" technology behind OraQuick® ADVANCE is similar to that used in a home pregnancy test. For the oral rapid test, oral fluid is collected by gently swabbing completely around the outer gums, both upper and lower, one time around, using the flat pad of the device. Then, the device is inserted into the vial of special solution provided. The result appears on the device as a prominent line, which becomes evident in about 20 minutes.

The national rate of HIV transmission continues to grow, especially in low-income, minority populations, with 40,000 new cases reported each year. Currently, at least 1 million Americans are living with HIV/AIDS.

Helping to increase the number of people who learn their HIV status will ultimately help prevent the spread of HIV and ensure more timely treatment for those infected.

For additional background information on rapid HIV tests, visit www.cdc.gov/hiv/rapid_testing.

For more information about the test, call 1 (800) 869-3538. End of Article

« See Also—Main Story—SAMHSA Launches Rapid HIV Testing Initiative

« See From the Administrator: HIV/AIDS: A New Effort Offers Hope

See Also—Next Article »

Back to Top

skip navigation
Inside This Issue

SAMHSA Launches Rapid HIV Testing Initiative
Related Content:
From the Administrator: HIV/AIDS: A New Effort Offers Hope
Facts About Rapid HIV Testing

21 States, 2 Territories Awarded Strategic Prevention Framework Grants
SAMHSA Announces Grant Awards
First Funding Opportunities for 2005

The Workforce Crisis: SAMHSA's Response
Related Content:
Related Resources

Special Web Article
Policy Academy Strives To Improve Services for Older Adults

SAMHSA Heads Drug-Free Communities Program

Buprenorphine Update: Mentoring Program Supports Physicians Treating Opioid Addiction

TIP 39: Integrating Substance Abuse Treatment and Family Therapy

2003 Survey: Marijuana Use Drops Among Youth, Risk Perceptions Climb
Related Content:
  • Chart—New Marijuana Users
  • Chart—Past-Year Perceived Need

    Helping State Agencies Weather '04 Hurricane Season

    In Brief…
    Preventive Services Publication Released
    New Treatment Booklet

    SAMHSA News in Print 2004 Index
  • Index A–D
  • Index E–M
  • Index N–R
  • Index S–Y

    SAMHSA News

    SAMHSA News - November/December 2004, Volume 12, Number 6

    SAMHSA Contracts | SAMHSA's Budget | Employment | Site Map
     SAMHSA Home  Contact the Staff  Accessibility  Privacy Policy  Freedom of Information Act
     Disclaimer  Department of Health and Human Services  The White House  First Gov